title: [Management of severe atopic dermatitis].
authors.affiliation: Clinique Dermatologique, CHU Hôtel-Dieu, Nantes.
authors.forename: J M
authors.initials: JM
authors.lastname: Chavigny
authors.forename: P
authors.initials: P
authors.lastname: Alzieu
authors.forename: B
authors.initials: B
authors.lastname: Milpied
authors.forename: H
authors.initials: H
authors.lastname: Dutartre
authors.forename: M
authors.initials: M
authors.lastname: Debons
authors.forename: J F
authors.initials: JF
authors.lastname: Stalder
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002648:Child; D003876:Dermatitis, Atopic / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D004781:Environmental Exposure / Q000009:adverse effects; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D018579:Patient Selection; D012307:Risk Factors; D012720:Severity of Illness Index; D013256:Steroids
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D006634:Histamine H1 Antagonists; D007166:Immunosuppressive Agents; D013256:Steroids